CLINICAL TRIAL SUMMARY

MDACC Study No:2009-0381 (clinicaltrials.gov NCT No: NCT00950001)
Title:Efficacy of Post-Surgical Stereotactic Radiosurgery for Metastatic Brain Disease: A Randomized Trial
Principal Investigator:Anita Mahajan
Treatment Agent:Stereotactic Radiosurgery
Study Status:Open
Study Description:The goal of this clinical research study is to learn if stereotactic
radiosurgery can help to reduce the risk of a brain tumor returning after
surgery. The safety of this treatment will also be studied.

Hide details for General InformationGeneral Information

Disease Group:Brain
Phase of Study:Phase III
Treatment Agents:Stereotactic Radiosurgery
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:n/a
Supported By:N/A
Return Visit:All patients will be undergo an MRI at 5-7 wks post craniotomy then every 6-9
wks for 1 year, then every 3 - 4 months thereafter. Patients will be removed
from the study once
Home Care:n/a


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Anita Mahajan
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2300
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults